AAAAAA

   
Results: 1-17 |
Results: 17
CLOPIDOGREL ACTIVITIES IN PATIENTS WITH RENAL-FUNCTION IMPAIRMENT
Authors: DERAY G BAGNIS C BROUARD R NECCIARI J LEENHARDT AF RAYMOND F BAUMELOU A
Citation: G. Deray et al., CLOPIDOGREL ACTIVITIES IN PATIENTS WITH RENAL-FUNCTION IMPAIRMENT, Clinical drug investigation, 16(4), 1998, pp. 319-328
AGING AND VENOUS THROMBOEMBOLISM INFLUENCE THE PHARMACODYNAMICS OF THE ANTI-FACTOR XA AND ANTI-THROMBIN ACTIVITIES OF A LOW-MOLECULAR-WEIGHT HEPARIN (NADROPARIN)
Authors: MISMETTI P LAPORTESIMITSIDIS S NAVARRO C SIE P DAZEMAR P NECCIARI J DURET JP GAUD C DECOUSUS H BONEU B
Citation: P. Mismetti et al., AGING AND VENOUS THROMBOEMBOLISM INFLUENCE THE PHARMACODYNAMICS OF THE ANTI-FACTOR XA AND ANTI-THROMBIN ACTIVITIES OF A LOW-MOLECULAR-WEIGHT HEPARIN (NADROPARIN), Thrombosis and haemostasis, 79(6), 1998, pp. 1162-1165
PHARMACODYNAMICS AND TOLERANCE OF 2 NADROPARIN FORMULATIONS (10,250 AND 20,500 ANTI XA IU-ML(-1)) DELIVERED FOR 10 DAYS AT THERAPEUTIC DOSE
Authors: BONEU B NAVARRO C CAMBUS JP CAPLAIN H DAZEMAR P NECCIARI J DURET JP GAUD C SIE P
Citation: B. Boneu et al., PHARMACODYNAMICS AND TOLERANCE OF 2 NADROPARIN FORMULATIONS (10,250 AND 20,500 ANTI XA IU-ML(-1)) DELIVERED FOR 10 DAYS AT THERAPEUTIC DOSE, Thrombosis and haemostasis, 79(2), 1998, pp. 338-341
AGING AND VENOUS THROMBOEMBOLISM INFLUENCE THE PHARMACODYNAMICS OF THE ANTI-XA AND ANTI-IIA ACTIVITIES OF A LOW-MOLECULAR-WEIGHT HEPARIN (NADROPARIN)
Authors: BONEU B MISMETTI P LAPORTE S NAVARRO C SIE P DAZEMAR P NECCIARI J DURET JP GAUD C DECOUSUS H
Citation: B. Boneu et al., AGING AND VENOUS THROMBOEMBOLISM INFLUENCE THE PHARMACODYNAMICS OF THE ANTI-XA AND ANTI-IIA ACTIVITIES OF A LOW-MOLECULAR-WEIGHT HEPARIN (NADROPARIN), Thrombosis and haemostasis, 1997, pp. 1149-1149
COMPARISON OF THE BIOAVAILABILITY OF 2 NADROPARIN FORMULATIONS (10000AND 20000 ANTI-XA IU.ML-1) IN HEALTHY-YOUNG VOLUNTEERS
Authors: BONEU B NAVARRO C CAMBUS JP CAPLAIN H DAZEMAR P NECCIARI J DURET JP GAUD C SIE P
Citation: B. Boneu et al., COMPARISON OF THE BIOAVAILABILITY OF 2 NADROPARIN FORMULATIONS (10000AND 20000 ANTI-XA IU.ML-1) IN HEALTHY-YOUNG VOLUNTEERS, Thrombosis and haemostasis, 1997, pp. 1160-1160
PHARMACOKINETICS OF TILUDRONATE IN PATIENTS WITH CHRONIC SEVERE RENAL-FAILURE
Authors: KESSLER M GRUNFELD J LASCOMBES F NECCIARI J
Citation: M. Kessler et al., PHARMACOKINETICS OF TILUDRONATE IN PATIENTS WITH CHRONIC SEVERE RENAL-FAILURE, Journal of bone and mineral research, 11, 1996, pp. 662-662
TILUDRONATE - PHARMACOKINETIC DOSE PROPORTIONALITY AFTER INTRAVENOUS ADMINISTRATION - ABSOLUTE BIOAVAILABILITY IN HEALTHY-VOLUNTEERS
Authors: JACOB F DEBRY G LASCOMBES F NECCIARI J
Citation: F. Jacob et al., TILUDRONATE - PHARMACOKINETIC DOSE PROPORTIONALITY AFTER INTRAVENOUS ADMINISTRATION - ABSOLUTE BIOAVAILABILITY IN HEALTHY-VOLUNTEERS, Journal of bone and mineral research, 11, 1996, pp. 663-663
STUDY OF THE PHARMACOKINETIC INTERACTION BETWEEN TILUDRONATE AND THE NONSTEROIDAL ANTIINFLAMMATORY DRUGS - ASPIRIN, DICLOFENAC AND INDOMETHACIN
Authors: CHASSARD D LASCOMBES F CREEK R NECCIARI J
Citation: D. Chassard et al., STUDY OF THE PHARMACOKINETIC INTERACTION BETWEEN TILUDRONATE AND THE NONSTEROIDAL ANTIINFLAMMATORY DRUGS - ASPIRIN, DICLOFENAC AND INDOMETHACIN, Journal of bone and mineral research, 11, 1996, pp. 664-664
TILUDRONATE - PHARMACOKINETICS IN PATIENTS WITH PAGETS-DISEASE OF BONE - COMPARISON WITH HEALTHY-VOLUNTEERS
Authors: PAPALEXIOU P DEBRY G NECCIARI J GOLDSTEIN N
Citation: P. Papalexiou et al., TILUDRONATE - PHARMACOKINETICS IN PATIENTS WITH PAGETS-DISEASE OF BONE - COMPARISON WITH HEALTHY-VOLUNTEERS, Journal of bone and mineral research, 11, 1996, pp. 765-765
MULTIPLE-DOSE PHARMACOKINETICS OF TILUDRONATE IN HEALTHY-VOLUNTEERS
Authors: SCHWIETERT HR PEETERS PAM DINGEMANSE J THIERCELIN JF NECCIARI J DEBRUIN H JONKMAN JHG
Citation: Hr. Schwietert et al., MULTIPLE-DOSE PHARMACOKINETICS OF TILUDRONATE IN HEALTHY-VOLUNTEERS, European Journal of Clinical Pharmacology, 51(2), 1996, pp. 175-181
HUMAN PHARMACOKINETICS OF TILUDRONATE
Authors: SANSOM LN NECCIARI J THIERCELIN JF
Citation: Ln. Sansom et al., HUMAN PHARMACOKINETICS OF TILUDRONATE, Bone, 17(5), 1995, pp. 479-483
PHARMACOKINETICS AND TOLERANCE OF THE NATURAL PENTASACCHARIDE (SR90107 ORG31540) WITH HIGH-AFFINITY TO ANTITHROMBIN-III IN MAN/
Authors: BONEU B NECCIARI J CARIOU R SIE P GABAIG AM KIEFFER G DICKINSON J LAMOND G MOELKER H MANT T MAGNANI H
Citation: B. Boneu et al., PHARMACOKINETICS AND TOLERANCE OF THE NATURAL PENTASACCHARIDE (SR90107 ORG31540) WITH HIGH-AFFINITY TO ANTITHROMBIN-III IN MAN/, Thrombosis and haemostasis, 74(6), 1995, pp. 1468-1473
INFLUENCE OF FOOD AND BODY-WEIGHT ON THE PHARMACOKINETICS OF PENTICAINIDE
Authors: BERDAI D DEMOTESMAINARD F PHILIP F VINCON G MONTELS R NECCIARI J BANNWARTH B
Citation: D. Berdai et al., INFLUENCE OF FOOD AND BODY-WEIGHT ON THE PHARMACOKINETICS OF PENTICAINIDE, Fundamental and clinical pharmacology, 8(5), 1994, pp. 453-457
CEFPIRAMIDE KINETICS AND PLASMA-PROTEIN BINDING IN CHOLESTASIS
Authors: DEMOTESMAINARD F VINCON G LABAT L AMOURETTI M NECCIARI J KIEFFER G BANNWARTH B
Citation: F. Demotesmainard et al., CEFPIRAMIDE KINETICS AND PLASMA-PROTEIN BINDING IN CHOLESTASIS, British journal of clinical pharmacology, 37(3), 1994, pp. 295-297
A DOUBLE WEIBULL INPUT FUNCTION DESCRIBES THE COMPLEX ABSORPTION OF SUSTAINED-RELEASE ORAL SODIUM VALPROATE
Authors: BRESSOLLE F GOMENI R ALRIC R ROYERMORROT MJ NECCIARI J
Citation: F. Bressolle et al., A DOUBLE WEIBULL INPUT FUNCTION DESCRIBES THE COMPLEX ABSORPTION OF SUSTAINED-RELEASE ORAL SODIUM VALPROATE, Journal of pharmaceutical sciences, 83(10), 1994, pp. 1461-1464
PHARMACOKINETICS OF THE NATURAL PENTASACCHARIDE (SR 90107A ORG31540) WITH HIGH-AFFINITY FOR ANTITHROMBIN-III FOLLOWING SUBCUTANEOUS ADMINISTRATION IN MAN/
Authors: BONEU B NECCIARI J MAGNANI H KIEFFER G MANT T MORRISON P SINGER B LAMOND G DICKINSON J
Citation: B. Boneu et al., PHARMACOKINETICS OF THE NATURAL PENTASACCHARIDE (SR 90107A ORG31540) WITH HIGH-AFFINITY FOR ANTITHROMBIN-III FOLLOWING SUBCUTANEOUS ADMINISTRATION IN MAN/, Thrombosis and haemostasis, 69(6), 1993, pp. 655-655
INFLUENCE OF FOOD-INTAKE ON THE PHARMACOKINETICS OF A SUSTAINED-RELEASE FORMULATION OF SODIUM VALPROATE
Authors: ROYERMORROT MJ ZHIRI A JACOB F NECCIARI J LASCOMBES F ROYER RJ
Citation: Mj. Royermorrot et al., INFLUENCE OF FOOD-INTAKE ON THE PHARMACOKINETICS OF A SUSTAINED-RELEASE FORMULATION OF SODIUM VALPROATE, Biopharmaceutics & drug disposition, 14(6), 1993, pp. 511-518
Risultati: 1-17 |